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BIA

:   benzylisoquiquinoline alkaloid

PS

:   *P. somniferum* seeds

RA

:   WS2981 *P. rhoeas* seeds from Hoengseong in the Province of Gangwon, South Korea

RS

:   Shiri *P. rhoeas* seeds from Moscow, Russia

RT

:   retention time

1. INTRODUCTION {#jssc5989-sec-0010}
===============

The annual flowering plant *Papaver rhoeas* L. (red poppy or corn poppy), is a species of the poppy family, Papaveraceae. It has been used in folk medicine for the treatment of inflammation, cough, diarrhea, respiratory problems, asthma, insomnia, and pain, and it can also be consumed as food [1](#jssc5989-bib-0001){ref-type="ref"}, [2](#jssc5989-bib-0002){ref-type="ref"}, [3](#jssc5989-bib-0003){ref-type="ref"}, [4](#jssc5989-bib-0004){ref-type="ref"}, [5](#jssc5989-bib-0005){ref-type="ref"}. Various phytochemical components can be found in corn poppy, such as alkaloids [2](#jssc5989-bib-0002){ref-type="ref"}, [6](#jssc5989-bib-0006){ref-type="ref"}, [7](#jssc5989-bib-0007){ref-type="ref"}, [8](#jssc5989-bib-0008){ref-type="ref"}, anthocyanins [9](#jssc5989-bib-0009){ref-type="ref"}, flavonoids [10](#jssc5989-bib-0010){ref-type="ref"}, and essential oils [11](#jssc5989-bib-0011){ref-type="ref"}. *P. rhoeas* can be cultivated in regions with a temperate climate. In Korea, it is widely distributed and is grown as an ornamental plant. This plant is sometimes mistaken for *Papaver somniferum* L. (PS), the strictly controlled opium poppy, containing narcotic substances such as morphine, codeine, and the baine [12](#jssc5989-bib-0012){ref-type="ref"}. Plants in the genus *Papaver* can produce diverse alkaloids, mainly in the form of benzylisoquiquinoline alkaloids (BIAs) [13](#jssc5989-bib-0013){ref-type="ref"}, [14](#jssc5989-bib-0014){ref-type="ref"}. Alkaloids from *Papaver* species possess significant biological activity [13](#jssc5989-bib-0013){ref-type="ref"}, [15](#jssc5989-bib-0015){ref-type="ref"}, and the alkaloid content of *Papaver* plants varies greatly depending on their growth stage, conditions, and origin [4](#jssc5989-bib-0004){ref-type="ref"}, [12](#jssc5989-bib-0012){ref-type="ref"}, [16](#jssc5989-bib-0016){ref-type="ref"}. Rapid and reliable analytical techniques must be developed to facilitate identification and structural determination of alkaloids in complex extracts and medicine herbs [17](#jssc5989-bib-0017){ref-type="ref"}, [18](#jssc5989-bib-0018){ref-type="ref"}, [19](#jssc5989-bib-0019){ref-type="ref"}, [20](#jssc5989-bib-0020){ref-type="ref"}, [21](#jssc5989-bib-0021){ref-type="ref"}, [22](#jssc5989-bib-0022){ref-type="ref"}, [23](#jssc5989-bib-0023){ref-type="ref"}. To discover medicinally relevant compounds and potential alternatives to plants as the commercial source of valuable BIAs, metabolomic studies of the *Papaver* species have been reported by metabolomics with chemometric approaches and transcript profiling [13](#jssc5989-bib-0013){ref-type="ref"}, [15](#jssc5989-bib-0015){ref-type="ref"}, [24](#jssc5989-bib-0024){ref-type="ref"}, [25](#jssc5989-bib-0025){ref-type="ref"}, [26](#jssc5989-bib-0026){ref-type="ref"}. However, to date, most studies have focused on the opium poppy and there have been few analytical studies on the alkaloids in *P. rhoeas* [4](#jssc5989-bib-0004){ref-type="ref"}, [12](#jssc5989-bib-0012){ref-type="ref"}. This is despite various reports on biological activity of its extracts based on both in vitro and in vivo experiments and clinical studies [4](#jssc5989-bib-0004){ref-type="ref"}, [5](#jssc5989-bib-0005){ref-type="ref"}, [7](#jssc5989-bib-0007){ref-type="ref"}, [27](#jssc5989-bib-0027){ref-type="ref"}. Many alkaloids likely present in this plant are yet to be identified. Therefore, investigation and identification of known and unknown alkaloids in *P. rhoeas* is needed for pharmacological studies, plant extract quality evaluations, and to understand species‐specific biosynthetic metabolism. This study aims to develop an analytical method based on LC--QTOF‐MS/MS for metabolite profiling and identification of alkaloids in *P. rhoeas* in a single LC run. Two types of *P. rhoeas* with different origins and one *P. somniferum* were cultivated and collected at different growth stages to measure the growth stage dependent variation of metabolites and to limit environmental influences. Samples collected at different time points were analyzed to achieve a more comprehensive understanding of BIA biosynthesis. The aim of the present study, in addition to developing novel LC--QTOF‐MS/MS methods, was to investigate alkaloids and their changes in *P. rhoeas* at different growth stages.

2. MATERIALS AND METHODS {#jssc5989-sec-0020}
========================

2.1. Plant material {#jssc5989-sec-0030}
-------------------

The aerial parts of *P. rhoeas* harvested at three different growth stages were provided by the National Academy of Agricultural Science, Rural Development Administration (Korea). The specimens used in this study were deposited in the Genomics Division of the National Academy of Agricultural Science. The two types of *P. rhoeas* seeds were of different origins; one (resource name: Shiri) originated from Moscow, Russia (RS) and the other (resource name: WS2981) originated from Hoengseong in the Province of Gangwon, South Korea (RA). The seeds were used after disinfection according to a method described elsewhere [28](#jssc5989-bib-0028){ref-type="ref"}, and pre‐processing with low temperature treatment at 4°C for 90 days [29](#jssc5989-bib-0029){ref-type="ref"}. Two types of *P. rhoeas* (RS and RA) and one type of *P. somniferum* (PS) were sown in April. The growth conditions were 26°C and relative humidity of 45% under natural light conditions in a glass greenhouse at the NAAS (latitude \[N 35° 49′ 53\'\'\]; longitude \[E 127° 3′ 48″\]) in the Republic of Korea. For the *Papaver* genus, the floral axis is observed at 60 days, and flower closing and fruit‐bearing occurs 90 days after germination. Hence, samples were collected at 30, 60, and 90 days.

2.2. Reagents and chemicals {#jssc5989-sec-0040}
---------------------------

Eighteen BIAs were purchased as authentic standards and are listed in Table [1](#jssc5989-tbl-0001){ref-type="table"}. The reference standard of demetylcoclaurine (20 mg; purity ≥ 98%) and tetrahydropapverine (10 mg; purity ≥ 98%) were purchased from ALB technology (Mongkok Kowloon, Hong Kong). Coclaurine (10 mg; purity ≥ 97.2%), corytuberine (10 mg; purity ≥ 98%), tetrahydroberberin (20 mg; purity ≥ 98%), berberine (20 mg; purity ≥ 98%), stylopine (10 mg; purity ≥ 98.3%), dihydrosanguinarine (10 mg; purity ≥ 98%), sanguinarine (20 mg; purity ≥ 99.8%), protopine (20 mg; purity ≥ 98.3%), and dihydroberberine (10 mg; purity ≥ 98%) were purchased from Chemface (Wuhan, China). (*S*)‐Reticuline (10 mg; purity ≥ 98%) and [l]{.smallcaps}‐reticule (10 mg; purity ≥ 98%) were purchased from Carbosynth (Berkshire, UK). Tetrahydrocolumbamine (10 mg; purity ≥ 98%) and scoulerine (10 mg; purity ≥ 98%) were purchased from ChemNorm biotech (Wuhan, China). [l]{.smallcaps}‐Tetrahydropalmatine (20 mg; purity ≥ 98%) and allocryptopine (20 mg; purity ≥ 98%) were purchased from Biopurify phytochemicals (Chengdu, China). Chelidonine (10 mg; purity ≥ 97%) was purchased from Sigma--Aldrich (St. Louis, MO). Acetonitrile (ACN) and methanol (MeOH) were purchased from Honeywell Burdick & Jackson (Morristown, NJ) and were of HPLC grade. Analytical‐grade formic acid (99% purity) and ammonium formate were obtained from Sigma--Aldrich. Deionized water (\>18 mΩ) was obtained by a pure water purification system (Human, Korea).

###### 

Retention time (RT), MS data, and BIA structural subgroups of the authentic alkaloids used in this study

  **Peak no**.   **Alkaloid name**                     **RT (min)**   **Formula**       **Adduct**   **Observed mass (Da)**   **Mass error (ppm)**   **BIA structural subgroups derived from the basic benzylisoquinoline subunit**
  -------------- ------------------------------------- -------------- ----------------- ------------ ------------------------ ---------------------- --------------------------------------------------------------------------------
  1              DL‐Demethylcoclaurine                 4.98           C~16~H~17~NO~3~   +H           272.1281                 −0.1                   Benzylsioquinoline
  2              Coclaurine                            6.01           C~17~H~19~NO~3~   +H           286.1438                 0.8                    Benzylsioquinoline
  3              Tetrahydropapaverine                  9.10           C~20~H~25~NO~4~   +H           344.1856                 1.0                    Benzylsioquinoline
  4              *S*‐Reticuline                        6.72           C~19~H~23~NO~4~   +H           330.1700                 0.8                    Benzylsioquinoline
  5              Corytuberine                          6.29           C~19~H~21~NO~4~   +H           328.1543                 0.8                    Aporphine
  6              [l]{.smallcaps}‐Reticuline            6.72           C~19~H~23~NO~4~   +H           330.1700                 0.8                    Benzylsioquinoline
  7              Tetrahydrocolumbamine                 8.37           C~20~H~23~NO~4~   +H           342.1700                 0.1                    Protoberberine (tetrahydroprotoberberine)
  8              Scoulerine                            6.57           C~19~H~21~NO~4~   +H           328.1543                 0.4                    Protoberberine (tetrahydroprotoberberine)
  9              [l]{.smallcaps}‐Tetrahydropalmatine   10.51          C~21~H~25~NO~4~   +H           356.1856                 0.9                    Protoberberine (tetrahydroprotoberberine)
  10             Tetrahydroberberine (canadine)        11.64          C~20~H~21~NO~4~   +H           340.1543                 0.8                    Protoberberine (tetrahydroprotoberberine)
  11             Berberine                             13.80          C~20~H~18~NO~4~                336.1236                 −0.6                   Protoberberine
  12             Stylopine                             10.85          C~19~H~17~NO~4~   +H           324.1230                 0.9                    Protoberberine (tetrahydroprotoberberine)
  13             Dihydrosanguinarine                   19.10          C~20~H~15~NO~4~   +H           334.1074                 1.4                    Benzophenanthridine
  14             Sanguinarine                          12.75          C~20~H~14~NO~4~                332.0923                 −0.6                   Benzophenanthridine
  15             Protopine                             9.22           C~20~H~19~NO~5~   +H           354.1336                 0.8                    Protopine
  16             Allocryptopine                        10.21          C~21~H~23~NO~5~   +H           370.1649                 0.1                    Protopine
  17             Chelidonine                           10.18          C~20~H~19~NO~5~   +H           354.1336                 −0.1                   Benzophenanthridine
  18             Dihydroberberine                      10.95          C~20~H~19~NO~4~   +H           338.1387                 0.1                    Protoberberine

John Wiley & Sons, Ltd.

2.3. Sample preparation {#jssc5989-sec-0050}
-----------------------

Aerial parts of the lyophilized *Papaver* species were first ground into a fine powder. Approximately 2 g of each sample was then ultrasonicated in 5 mL of ethanol for 30 min, and centrifuged at 13 000 rpm for 15 min at 4°C. The supernatants were filtered through a 0.2 μm polytetrafluoroethylene syringe filter (Thermo Scientific, Waltham, MA). Finally, the filtrate was diluted with ethanol to 20 mg/mL and transferred to an LC sample vial before use.

2.4. LC and MS analysis conditions {#jssc5989-sec-0060}
----------------------------------

The LC--MS system consisted of a Thermo Scientific Vanquish UHPLC system (Thermo Fisher Scientific, Sunnyvale, CA) with an Acquity UPLC HSS T3 column (2.1 × 100 mm, 1.7 μm; Waters, Milford, MA) and a Triple TOF 5600^+^ mass spectrometer system (Triple TOF MS; QTOF, Sciex, Foster City, CA). The QTOF‐MS, equipped with a Duospray™ ion source, was used to complete the high‐resolution experiment. The LC gradient used a mobile phase A containing 0.05% formic acid and 2.5 mM ammonium formate in water and a mobile phase B of acetonitrile. The flow rate was kept constant at 0.4 mL/min and the injection volume was 1 μL. The gradient elution system began at 1% B for 2.5 min, 1 to 10% B from 2.5 to 3.0 min, 10 to 19% B from 3.0 to 6.0 min, 19 to 22% from 6.0 to 9.0 min, 22 to 25% B from 9.0 to 14.0 min, 25 to 70% B from 14.0 to 17.0 min, and then increased to 100% B at 19.0 min, held at 100% B for 3 min and then returned to the initial conditions for re‐equilibration.

Mass data acquisition was performed with a Triple TOF 5600^+^ in positive ion mode using the following parameters: source temperature was set at 450°C with a curtain gas flow of 25 L/min (GS1 and GS2 both 50), the ion spray voltage was set at 4500 V, declustering potential was 50 V, and the collision energy was 10 V. High‐purity nitrogen gas was used for the nebulizer/Duospray™ and curtain gases. The QTOF and information‐dependent acquisition scan was operated with a mass range of 50 to 1500 *m/z*. Precursor and product ion calibration were performed in both high sensitivity and high‐resolution modes using a calibrant delivery system before analysis.

Data acquisition and processing were carried out using Analyst TF 1.7, PeakVeiw 2.2, MarterView, and MarkerView 1.2 software (Sciex).

3. RESULTS AND DISCUSSION {#jssc5989-sec-0070}
=========================

3.1. Sample preparation {#jssc5989-sec-0080}
-----------------------

Five different extraction solvents were examined for effectiveness in metabolite extraction from the aerial parts of plants: 50 and 80% methanol in water, pure methanol, pure ethanol, and ethyl ether with 10% ammonia. Samples were extracted and analyzed by the LC--QTRAP (hybrid triple quadrupole/linear ion trap) MS system (ABSCIEX, Foster City, CA). To study the effects of the extraction process on metabolite quantitation, the peak intensities of the extracted metabolites were compared. As a first approximation, a gradient system developed in a previous study was used [30](#jssc5989-bib-0030){ref-type="ref"}. The protopine authentic metabolite was detected in all tested samples. When ethyl ether was used, the peak area of protopine was the highest of all the extraction solvents tested, as shown in Supporting information Table S1 and Figure S1. According to the peak areas, the efficiency of extraction solvents was as follows: ethyl ether with 10% ammonia \> pure ethanol \> 80% methanol in water \> methanol \> 50% methanol in water. However, ethyl ether is volatile, and its extracts require additional sample preparation steps including evaporation and re‐dilution to obtain reproducible data. For metabolomics, sample preparation should be easy, convenient, robust, and reproducible, especially for large‐scale analyses. Therefore, ethanol, the second most efficient extraction solvent was selected as the ideal extraction solvent for the aerial parts of *P. rhoeas* and *P. somniferum*.

3.2. LC--MS analysis {#jssc5989-sec-0090}
--------------------

Several previous studies analyzed and separated BIAs using similar analytical techniques as presented here [17](#jssc5989-bib-0017){ref-type="ref"}, [18](#jssc5989-bib-0018){ref-type="ref"}, [19](#jssc5989-bib-0019){ref-type="ref"}, [30](#jssc5989-bib-0030){ref-type="ref"}, [31](#jssc5989-bib-0031){ref-type="ref"}, [32](#jssc5989-bib-0032){ref-type="ref"}. The simultaneous analysis of the alkaloids with different skeletons present in the *Papaver* genus is not a simple task. The chromatographic retention behavior of alkaloids on an RP column significantly decreases at low pH, and significantly increases at neutral pH [33](#jssc5989-bib-0033){ref-type="ref"}, [34](#jssc5989-bib-0034){ref-type="ref"}. To optimize the gradient and mass spectrometer conditions, analysis of a mixture of 18 authentic standards (Table [1](#jssc5989-tbl-0001){ref-type="table"}) was performed with the UHPLC--QTOF system. To identify suitable chromatographic conditions, different elution systems were tested and their selectivity, sensitivity, resolution, tailing factor, and peak widths were considered as important parameters. First, a gradient system with the mobile phases of 5 mM ammonium formate in water (A) and acetonitrile (B) was optimized on C18 and pentafluorophenyl columns. Although the pentafluorophenyl column separated allocryptopine, protopine, and chelidonine well, which were not separated by the C18 column, it showed peak broadening of (dihydro)berberine and (dihydro)sanguinarine using 5 mM ammonium acetate or ammonium formate as mobile‐phase adducts. In addition, the repeatability was suboptimal because of retention time (RT) drift. The aqueous C18 column, compatible with 100% aqueous mobile phase, exhibited more reproducible RTs and was selected as the ideal analytical column for the LC--QTOF‐based metabolomic analysis of alkaloids in *P. rhoeas*. Then, three elution conditions were tested on the Acquity UPLC HSS T3 column; 5 mM ammonium formate, 0.1% formic acid, and a combination of 0.05% formic acid and 2.5 mM ammonium formate as additives. Based on the optimized gradient system, elutions with different additives were performed on the authentic standards and the results are shown in Figure [1](#jssc5989-fig-0001){ref-type="fig"}. The chromatographic separation and resolution among authentic standards were good for the ammonium formate additive, as shown in Figure [1](#jssc5989-fig-0001){ref-type="fig"}A, but peak tailing and broadening were observed. This resulted in peak splitting and difficulties during the metabolomics data pre‐processing for samples containing a complex mixture of metabolites. As shown in Figure [1](#jssc5989-fig-0001){ref-type="fig"}B, the use of moderately acidic additives improved the chromatographic properties when compared to ammonium formate alone. The use of 0.05% formic acid together with the addition of 2.5 mM ammonium formate improved the chromatographic resolution and detection sensitivity of the alkaloids (Figure [1](#jssc5989-fig-0001){ref-type="fig"}C), which agrees well with the literature [33](#jssc5989-bib-0033){ref-type="ref"}.

![Representative extracted ion chromatography (XIC) of 18 authentic standards with different mobile phase compositions: 5 mM ammonium formate in water/acetonitrile (A), 0.1% formic acid in water/acetonitrile (B), 2.5 mM ammonium formate and 0.05% formic acid in water/acetonitrile (C); (1) [dl]{.smallcaps}‐demethylcoclaurine, (2) coclaurine, (3) tetrahydropapaverine, (4) *S*‐reticuline, (5) corytuberine, (6) [l]{.smallcaps}‐reticuline, (7) tetrahydrocolumbamine, (8) scoulerine, (9) [l]{.smallcaps}‐tetrahydropalmatine, (10) tetrahydroberberine, (11) berberine, (12) stylopine, (13) dihydrosanguinarine, (14) sanguinarine, (15) protopine, (16) chelidonine, (17) allocryptopine, and (18) dihydroberberine](JSSC-41-2517-g001){#jssc5989-fig-0001}

3.3. Identification of the alkaloids {#jssc5989-sec-0100}
------------------------------------

Eighteen authentic standards representing the major alkaloids in *Papaver* genus were analyzed by LC--QTOF with the column described in Section 2 and optimized LC conditions. Table [1](#jssc5989-tbl-0001){ref-type="table"} summarizes the chromatographic information (RTs) and MS‐based information (adduct forms, observed mass, product ions). Highly abundant protonated molecule \[M+H\]^+^ ions of most alkaloids, except for the peak no. 11 (berberine) and 14 (sanguinarine), were observed in the ESI mass spectra due to the strong basicity of the secondary or tertiary amine group. Characteristically, berberine and sanguinarine showed strong intensities of intact \[M\]^+^ ion in the ESI‐MS analysis because of the cation on the nitrogen atom as explained in the previous report [35](#jssc5989-bib-0035){ref-type="ref"}.

The MS/MS spectra of the authentic standards are shown in Supporting Information Figure S2 and were used for identification of alkaloids from the *P. rhoeas* (RS and RA) and *P. somniferum* (PS) samples. In addition, structural information such as formula and fragment patterns of many of the BIAs have been previously reported [2](#jssc5989-bib-0002){ref-type="ref"}, [6](#jssc5989-bib-0006){ref-type="ref"}, [8](#jssc5989-bib-0008){ref-type="ref"}, [13](#jssc5989-bib-0013){ref-type="ref"}, [14](#jssc5989-bib-0014){ref-type="ref"}, [24](#jssc5989-bib-0024){ref-type="ref"}, [30](#jssc5989-bib-0030){ref-type="ref"}, [36](#jssc5989-bib-0036){ref-type="ref"}. This information combined with the in‐house library on the Sciex instrument and online databases such as Metlin and MS bank were used for the tentative identification of various alkaloids in the RS, RA, and PS samples collected at 30, 60, and 90 days. As can be seen in Figure [2](#jssc5989-fig-0002){ref-type="fig"}, the samples taken at 90 days show quite different chromatograms because they are composed of a larger variety of metabolites (the chromatograms of the other samples are shown in Supporting Information Figure S3). The identification of each component in the extract was first analyzed by comparison to authentic standards (Table [1](#jssc5989-tbl-0001){ref-type="table"}) with MasterView in the PeakView software. Eight metabolites, demethylcoclaurine, coclaurine, (*R*/*S*)‐reticuline, stylopine, dihydrosanguinarine, and protopine were identified in the three samples during all growth stages even though their abundance varied depending on species and growth stage. Protopine (a protopine‐type alkaloid) and stylopine (a tetrahydroprotoberberine‐type alkaloid) from the RA and RS samples were more abundant during early growth stage (30 days) than at 60 and 90 days and could be characteristic metabolites of *P. rhoeas* (Figure [3](#jssc5989-fig-0003){ref-type="fig"}). [dl]{.smallcaps}‐Demethylcoclaurine, coclaurine, and (*R*/*S*)‐reticuline (a benzylisoquinoline‐type alkaloid) and corytuberine (an aporphine‐type alkaloid) were observed in low abundance in RS and RA, but in the PS samples, these alkaloids significantly increased over the course of the growth process. Tetrahydrocolumbamine, tetrahydropalmatine, and tetrahydroberberine (a tetrahydroprotoberberine‐type alkaloid) and berberine (a protoberberine‐type alkaloid) were found in low abundance and only in the RS samples harvested at 30 and 90 days. Sanguinarine (a benzophenanthridine‐type alkaloid) was found only in the RS samples at 60 days. Also, dihyrosanguinarine (a benzophenanthridine‐type alkaloid) in the RS samples harvested at 60 days was significantly more abundant than the other specimens. Tetrahydropapaverine (a papaverine‐type alkaloid), scoulerine (a protoberberine‐type alkaloid), and allocryptopine (a protopine‐type alkaloid) were not observed in either RS or RA samples. Dihydroberberine (a protoberberine‐type alkaloid) and chelidonine (a benzophenanthridine‐type alkaloid) were not observed in any samples. According to the results, there is no significant change of representative metabolites in BIA biosynthesis from *P. rhoeas* (RS and RA).

![Representative base peak ion chromatograph (BPC) of the ethanol extracts of RS at 90 days (A), RA at 90 days (B), and PS at 90 days (C). The two types of *Papaver rhoeas* seeds have different origins; one (resource name: Shiri) originated from Moscow, Russia (RS) and the other (resource name: WS2981) originated from Hoengseong in the Province of Gangwon, South Korea (RA)](JSSC-41-2517-g002){#jssc5989-fig-0002}

![Representative metabolite intensities as determined by LC--QTOF analysis for samples at different growth stages (30, 60, and 90 cultivating days): [dl]{.smallcaps}‐demethylcoclaurine (1), coclaurine (2), tetrahydropapaverine (3), (*R*/*S*)‐reticuline (4 and 6), corytuberine (5), [l]{.smallcaps}‐tetrahydropalmatine (7), scoulerine (8), [l]{.smallcaps}‐tetrahydropalmatine (9), tetrahydroberberine (10), berberine (11), stylopine (12), dihydrosanguinarine (13), sanguinarine (14), protopine (15), allocryptopine (16), and rhoeadine (42). The ratio is the peak intensity of a metabolite in a sample that was divided by the peak intensity of a blank sample and expressed in a logarithmic scale. Compounds 1--16 were identified by authentic standards and the remaining 43 were identified tentatively by isotope patterns and comparison to database or previous literature](JSSC-41-2517-g003){#jssc5989-fig-0003}

For further identification of the alkaloids, the LC--QTOF base peak chromatogram collected in information‐dependent acquisition scan mode was processed to search and screen alkaloid metabolites by exact masses against an in‐house library and databases such as Chemspider, Metlin, and MS bank. The proposed identity of the alkaloid was compared to the RT and characteristic product ions (fragmentation patterns) in the reference MS/MS spectra. A total of 54 alkaloids were identified or tentatively identified in the base peak chromatograms of the RA, RS, and PS samples. Table [2](#jssc5989-tbl-0002){ref-type="table"} lists the benzylisoquinoline alkaloids that could be authentically or tentatively identified in the samples by the developed LC--QTOF‐MS/MS method. Alkaloids identified or tentatively identified in the aerial parts of the cultivated *P. rhoeas* and *P. somniferum* are summarized in Supporting Information Table S2. Also, metabolites (colored or bold text) from *P. rhoeas* (RS and RA) identified in benzylisoquinoline alkaloid (BIA) biosynthesis pathways [24](#jssc5989-bib-0024){ref-type="ref"} were marked as shown in Supporting Information Figure S4. Further analysis of precursors of BIA was conducted by LC--QTOF. The precursors such as tyrosine, 4‐hydroxyphenyacetaldehyde, tyramine, dopamine due to polarity were effectively extracted with distilled water from aerial parts of RS and RA. Those were identified, and intensities as determined by LC--QTOF analysis for samples at different growth stages (30, 60, and 90 cultivating days) are expressed in Supporting Information Figure S4. Tyramine, dopamine, and 4‐hydroxyphenyacetaldehyde increased during growth, and the contents of tyramine increased significantly. Stylopine, protopine, and rhoeadine were mainly observed as secondary metabolites over all stages from the aerial parts of *P. rhoeas*.

###### 

Characterization of the benzylisoquinoline alkaloids by LC--QTOF‐MS

  **Peak no**.   **Name**                                                 **Formula**        **Expected RT (min)**   **Predicted mass (Da)**   **Adduct form \[M\]^+^ or \[M+H\]^+^**   **Observed mass (Da)**   **Product ions (MS/MS fragment ions, *m/z*)**
  -------------- -------------------------------------------------------- ------------------ ----------------------- ------------------------- ---------------------------------------- ------------------------ --------------------------------------------------
  1              DL‐Demethylcoclaurine                                    C~16~H~17~NO~3~    4.98                    271.1208                  \[M+H\]^+^                               272.1281                 107.0493, 255.1015, 161.0591, 143.0490
  2              Coclaurine                                               C~17~H~19~NO~3~    6.03                    285.1365                  \[M+H\]^+^                               286.1438                 107.0494, 269.1167, 175.0744, 237.0905
  3              Tetrahydropapaverine                                     C~20~H~25~NO~4~    9.11                    343.1784                  \[M+H\]^+^                               344.1856                 192.1023, 189.0912, 151.0757, 327.1600
  4 & 6          Reticuline                                               C~19~H~23~NO~4~    6.74                    329.1627                  \[M+H\]^+^                               330.1700                 192.1017, 137.0598, 143.0490, 175.0749
  5              Corytuberine                                             C~19~H~21~NO~4~    6.28                    327.1471                  \[M+H\]^+^                               328.1543                 265.0859, 237.0908, 297.1122, 205.0644
  7              Tetrahydrocolumbamine                                    C~20~H~23~NO~4~    8.38                    341.1627                  \[M+H\]^+^                               342.1700                 178.0870, 163.0634, 176.0711
  8              Scoulerine                                               C~19~H~21~NO~4~    6.57                    327.1471                  \[M+H\]^+^                               328.1543                 237.0919, 207.0445, 211.0758, 239.0707
  9              [l]{.smallcaps}‐Tetrahydropalmatine                      C~21~H~25~NO~4~    10.53                   355.1784                  \[M+H\]^+^                               356.1856                 192.1017, 165.0905, 176.0700
  10             Tetrahydroberberine (canadine)                           C~20~H~21~NO~4~    11.68                   339.1471                  \[M+H\]^+^                               340.1543                 176.0707, 149.0595, 174.0548
  11             Berberine                                                C~20~H~18~NO~4~    13.83                   336.1236                  \[M\]^+^                                 336.1236                 320.0922, 292.0970, 321.1000, 306.0762, 278.0813
  12             Stylopine                                                C~19~H~17~NO~4~    10.94                   323.1158                  \[M+H\]^+^                               324.1230                 176.0705, 149.0596
  13             Dihydrosanguinarine                                      C~20~H~15~NO~4~    19.10                   333.1001                  \[M+H\]^+^                               334.1074                 318.0764, 319.0842, 304.0967, 276.1016
  14             Sanguinarine                                             C~20~H~14~NO~4~    12.77                   332.0923                  \[M\]^+^                                 332.0923                 317.0683, 274.0861, 304.0969
  15             Protopine                                                C~20~H~19~NO~5~    9.22                    353.1263                  \[M+H\]^+^                               354.1336                 188.0702, 189.0778, 149.0591
  16             Allocryptopine                                           C~21~H~23~NO~5~    10.21                   369.1576                  \[M+H\]^+^                               370.1649                 188.0701, 189.0780, 290.0939
  17             Chelidonine                                              C~20~H~19~NO~5~    10.18                   353.1263                  \[M+H\]^+^                               354.1336                 275.0704, 247.852, 305.0815, 323.0917
  18             Dihydroberberine                                         C~20~H~19~NO~4~    10.95                   337.1314                  \[M+H\]^+^                               338.1387                 322.1071, 294.1123, 308.0914, 279.0876
  19             Tyramine                                                 C~8~H~11~NO        1.91                    137.0841                  \[M+H\]^+^                               138.0913                 77.0401, 121.0649, 103.0536, 91.0551
  20             Dopamine                                                 C~8~H~11~NO~2~     0.89                    153.0790                  \[M+H\]^+^                               154.0863                 91.0599, 137.0600, 119.0496
  21             4‐Hydroxyphenylacetaldehyde                              C~8~H~8~NO~2~      0.89                    136.0524                  \[M+H\]^+^                               137.0597                 91.0551, 65.0420, 119.0501, 63.0269
  22             Morphine                                                 C~17~H~19~NO~3~    4.10                    285.1365                  \[M+H\]^+^                               286.1438                 201.0900, 229.0849, 185.0584, 211.0747
  23             Mecambrine                                               C~18~H~17~NO~3~    7.68                    295.1208                  \[M+H\]^+^                               296.1281                 202.0853, 171.0674, 280.0965
  24             Codeine                                                  C~18~H~21~NO~3~    5.08                    299.1521                  \[M+H\]^+^                               300.1594                 215.1064, 243.1013, 225.0906, 199.0748
  25             (*S*)‐*N‐*Methylcoclaurine                               C~18~H~21~NO~3~    6.09                    299.1521                  \[M+H\]^+^                               300.1594                 269.1180, 107.0495, 271.1348
  26             Armepavine                                               C~19~H~23~NO~3~    5.64                    313.1678                  \[M+H\]^+^                               314.1751                 107.0495, 58.0675, 269.1160, 271.1328, 298.1070
  27             (*S*)‐3′‐Hydroxy‐*N*‐methylcoclaurine                    C~18~H~21~NO~4~    5.53                    315.1471                  \[M+H\]^+^                               316.1543                 192.1010, 123.0430, 285.1116, 300.1196
  28             (*S*)‐Cheilanthifoline                                   C~19~H~19~NO~4~    7.70                    325.1314                  \[M+H\]^+^                               326.1387                 178.0865, 190.0862, 163.0625
  29             Papaverine                                               C~20~H~21~NO~4~    10.15                   339.1471                  \[M+H\]^+^                               340.1543                 202.0867, 324.1216, 296.1288, 171.0683
  30             Cryptopine                                               C~21~H~23~NO~5~    8.97                    369.1576                  \[M+H\]^+^                               370.1649                 352.1190, 205.1099, 165.0913, 190.0862
  31             Noscapine                                                C~22~H~23~NO~7~    10.59                   413.1475                  \[M+H\]^+^                               414.1547                 220.0967, 353.1030, 365.1032, 179.0705
  32             4‐Hydroxyphenylpyruvate                                  C~9~H~8~O~4~       4.86                    180.0423                  \[M+H\]^+^                               181.0495                 89.0402, 135.0438, 163.0396, 145.0291, 117.0345
  33             Codeinone                                                C~18~H~19~NO~3~    5.64                    297.1365                  \[M+H\]^+^                               298.1438                 283.1208, 282.1125, 254.1180, 266.1213
  34             Morphine *N*‐oxide                                       C~17~H~19~NO~4~    4.16                    301.1314                  \[M+H\]^+^                               302.1387                 284.1280, 241.0860
  35             Flavinantine                                             C~19~H~21~NO~4~    7.17                    327.1471                  \[M+H\]^+^                               328.1543                 178.0855, 163.0621
  36             8,14‐dihydroflavinantine (or salutaridinol)              C~19~H~23~NO~4~    5.05                    329.1627                  \[M+H\]^+^                               330.1700                 285.1121, 123.0435, 58.0665, 143.0482
  37             (*S*)‐*cis*‐*N*‐Methylstylopine                          C~20~H~20~NO~4~    10.20                   338.1392                  \[M+H\]^+^                               339.1465                 191.0891, 190.0857, 149.0589
  38             Isocorydine                                              C~20~H~23~NO~4~    7.25                    341.1627                  \[M+H\]^+^                               342.1700                 297.1120, 265.0856, 237.0904
  39             Pseudoprotopine                                          C~20~H~19~NO~5~    7.69                    353.1263                  \[M+H\]^+^                               354.1336                 188.0703, 189.0775, 149.0592
  40             Amurensinine *N*‐oxide A (or amurensinine *N*‐oxide B)   C~20~H~21~NO~5~    7.61                    355.1420                  \[M+H\]^+^                               356.1493                 190.0567, 191.0944, 277.0864, 151.0756
  41             Rheagenine (or isorheagenine)                            C~20~H~19~NO~6~    10.19                   369.1212                  \[M+H\]^+^                               370.1285                 352.1185, 340.1180, 324.1226
  42             Rhoeadine (or isorhoeadine)                              C~21~H~21~NO~6~    7.27                    383.1369                  \[M+H\]^+^                               384.1442                 321.0763, 303.0649, 291.0653, 366.1341
  43             Glaucamine (or isoglaucamine)                            C~21~H~23~NO~6c~   8.64                    385.1525                  \[M+H\]^+^                               386.1598                 368.1499, 338.1042
  44             Coptisine                                                C~19~H~14~NO~4~    10.75                   320.0923                  \[M\]^+^                                 320.0923                 292.0964, 277.0728, 290.0805, 318.0755, 262.0858
  45             Unknown M1                                               C~16~H~17~NO~3~    4.98                    271.1208                  \[M+H\]^+^                               272.1281                 227.1772, 107.0496, 161.0580, 209.1688, 255.1030
  46             Unknown M2                                               C~17~H~17~NO~3~    4.32                    283.1208                  \[M+H\]^+^                               284.1281                 175.0568, 129.0169, 203.0549, 227.0707
  47             Unknown M3                                               C~18~H~19~NO~3~    5.64                    297.1365                  \[M+H\]^+^                               298.1438                 283.1211, 254.1180, 177.0774, 148.0776, 107.0498
  48             Unknown M4                                               C~19~H~21~NO~3~    7.60                    311.1521                  \[M+H\]^+^                               312.1594                 267.1008, 252.0774, 181.0599, 121.0299
  49             Unknown M5                                               C~18~H~21~NO~4~    5.32                    315.1471                  \[M+H\]^+^                               316.1543                 298.1430, 283.1218, 254.1169, 121.0647
  50             Unknown M6                                               C~19~H~21~NO~4~    7.18                    327.1471                  \[M+H\]^+^                               328.1543                 178.0855, 163.0616, 151.0750, 91.0572, 176.0685
  51             Unknown M7                                               C~21~H~21~NO~6~    10.45                   383.1369                  \[M+H\]^+^                               384.1442                 352.1180, 190.0863, 188.0710, 303.0653, 334.1077
  52             Unknown M8                                               C~21~H~24~NO~4~    9.81                    354.1705                  \[M+H\]^+^                               355.1778                 207.1204, 206.1172, 191.0913,
  53             Unknown M9                                               C~22~H~25~NO~6~    7.22                    399.1682                  \[M+H\]^+^                               400.1755                 337.1073, 319.0962, 204.1006, 58.0684, 382.1637
  54             Unknown M10                                              C~20~H~19~NO~4~    13.81                   337.1314                  \[M+H\]^+^                               338.1387                 321.0953, 322.1021, 293.1003, 307.0820
  55             Unknown M11                                              C~21~H~21~NO~6~    12.20                   383.1369                  \[M+H\]^+^                               384.1442                 352.1180, 190.0861, 320.0923, 291.0654, 263.0704

Peak no. 1--18 identified by direct comparison to authentic standards.

Peak no. 19 and 20 tentatively identified by comparison to the in‐house MS/MS library (Sciex) and Metlin database.

Peak no. 21--29 tentatively identified by comparison to the Metlin database.

Peak no. 30 and 31 tentatively identified by comparison to the MS bank database.

Peak no. 32--44 tentatively identified by isotope MS pattern and previous reports.

Peak no. 45--55 unknown.
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4. CONCLUDING REMARKS {#jssc5989-sec-0110}
=====================

In this study, an effective LC--QTOF‐MS/MS method was developed for the simultaneous identification of alkaloids in *Papaver* species. Alkaloids in *P. rhoeas* were separated and analyzed by LC--QTOF in a single run. Simultaneously, narcotic substances such as morphine and codeine derived from the opium poppy could be monitored. This could be helpful in the discrimination between species in the genus *Papaver*, as some are controlled substances whereas others are commonly found ornamental plants. In this first attempt to investigate the content, abundance, and identity of alkaloids present during the growth of *P. rhoeas*, information related to the growth stage and origin could be useful in understanding the biosynthesis and metabolism of alkaloids in *P. rhoeas*, even those in low abundance using MS‐based metabolite profiling.
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